NanoPin has a diagnostic platform for infectious diseases that pulls targeted biomarkers directly from blood samples and greatly amplifies signal strength to rapidly detect and enable optimal treatment. It is a powerful and versatile rapid response platform that will combat future contagions and will be initially commercialized in the tuberculosis (TB) diagnostic market, which will exceed $3 Billion by 2024 . Unlike currently available tools, this technology provides quantified results that not only tells a patient if they have a disease, but how severe it is and how it changes over time and during treatment.https://www.ceigateway.com/client-profiles/nanopin-technologies

Managing business development and client acquisition. Clients located in USA and Japan.• Nanotechnology and manufacturing consulting services• Optical device sales and services

Reported to the CEO of Polarization Solutions (and Board Member of Iwasaki Electric). Led production of UV Polarizer product line for LCD Manufacturing equipment, focusing mainly within Asia, primarily in Japan, Korea and Taiwan. Hired, trained and managed a team of 10.• Leveraged IP portfolio for LCD application in relation to market & competitors• Met with major LCD manufacturers and Apple to gain firsthand customer requirements and enable the technology in the industry• Collaborated with Japan parent company on strategic development, sales & marketing, budgeting, and infrastructure plans

Reported to the CEO of Polarization Solutions• Promoted to Executive Vice President in recognition for already managing division operations with limited oversight from parent company, successful transitioning from product development to full production, improving yields.

Reported to the CEO of Abraxis BioSensors (who reported directly to the CEO of the parent company Abraxis BioScience) Directed new initiative for biosensor development for personalized medicine application. Hired, trained and managed a team of 12.• Administered staff changes for key employee selection for efficiency and optimized cost structure• Pioneered effort to incorporate leading UV polarizer product line into emerging UV photo-alignment application for LCD display manufacturing

Reported to API Technologies CEO and CTO. Responsible for the commercialization of existing technology and development of market-focused new products. Hired, trained and managed a team of 16.• Implemented major shift in production to circumvent supply chain conflicts• Managed patent portfolio for NanoOpto and parent corporation (API Technologies Corporation)• Filed and co-inventor on several patent applications covering optical and optoelectronic devices and methods as well as new SERS platform technology

Hired, trained and directed a team of 3 researchers focused on nanotubes, nanowires, and next generation electronic devices.• Aided in systems and product development and sales• Inventor and writer of several patents including scaled up processes for integrated nanostructure electronics, nanostructure commercial equipment, and nanostructure transistor and rectifier devices